다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
23andMe Holding Company (ME)
23andMe Holding Company (ME) 뉴스

ME

23andMe (ME)

23andMe Holding Company

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ME

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/08/01	21:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/08/01	21:00	GlobeNewswire Inc.	23andMe Announces CEO’s Take-Private Proposal	NASDAQ:ME	23andMe Holding Company
2024/08/01	06:01	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:ME	23andMe Holding Company
2024/07/26	05:45	GlobeNewswire Inc.	23andMe to Report Q1 FY2025 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/07/25	20:30	GlobeNewswire Inc.	Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research	NASDAQ:ME	23andMe Holding Company
2024/07/17	05:54	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ME	23andMe Holding Company
2024/07/17	05:53	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ME	23andMe Holding Company
2024/07/17	05:52	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ME	23andMe Holding Company
2024/06/28	20:00	GlobeNewswire Inc.	23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel	NASDAQ:ME	23andMe Holding Company
2024/06/11	05:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/06/05	20:00	GlobeNewswire Inc.	23andMe Launches New Genetic Report on Bipolar Disorder	NASDAQ:ME	23andMe Holding Company
2024/06/04	20:00	GlobeNewswire Inc.	23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community	NASDAQ:ME	23andMe Holding Company
2024/06/03	21:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/06/03	21:00	GlobeNewswire Inc.	23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting	NASDAQ:ME	23andMe Holding Company
2024/05/29	21:00	GlobeNewswire Inc.	Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history	NASDAQ:ME	23andMe Holding Company
2024/05/25	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/05/24	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/05/24	05:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/05/24	05:05	GlobeNewswire Inc.	23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/05/22	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/05/22	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/05/14	20:00	GlobeNewswire Inc.	Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals	NASDAQ:ME	23andMe Holding Company
2024/05/11	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/05/10	05:50	GlobeNewswire Inc.	23andMe to Report Q4 and Full Year FY2024 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/05/01	00:00	Business Wire	Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case	NASDAQ:ME	23andMe Holding Company
2024/04/25	05:05	GlobeNewswire Inc.	23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:ME	23andMe Holding Company
2024/04/18	21:00	GlobeNewswire Inc.	23andMe announces CEO’s intention to pursue a potential take-private	NASDAQ:ME	23andMe Holding Company
2024/04/06	05:05	GlobeNewswire Inc.	23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:ME	23andMe Holding Company
2024/03/20	20:30	GlobeNewswire Inc.	23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6	NASDAQ:ME	23andMe Holding Company
2024/03/19	21:00	GlobeNewswire Inc.	23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago	NASDAQ:ME	23andMe Holding Company

검색 관련기사 보기:NASDAQ:ME

1 2 3 4 5 6 7 8 9 10 다음 >>

American Express

Health Care Select Sector

US Dollar vs Yen

Energy Select Sector SPDR

US Dollar vs Sterling

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관